[ Price : $8.95]
FDA says that Mizuhos recall of its OSI modular table systems due to the potential for patient injuries is a Class 1 recall.[ Price : $8.95]
CDER director Janet Woodcock discusses her concept of building quality in cooperatively to the structure of drug clinical trials....[ Price : $8.95]
The Congressional Budget Office estimates a reduction in federal budget deficits of nearly $5 billion over 10 years from a bill to...[ Price : $8.95]
Recently retired CDRH Office of Compliance director Tim Ulatowski joins Becker & Associates Consulting in the firms Washington, DC...[ Price : $8.95]
FDA and NephroGenex reach agreement on the design of a new Phase 3 Subpart H (accelerated approval) program that evaluates Pyridor...[ Price : $8.95]
The Tufts Center for the Study of Drug Development says that the number of monoclonal antibodies in clinical study has been steadi...[ Price : $8.95]
An Institute of Medicine report says that FDA may have to regulate health IT safety if the private and public sectors cant make su...[ Price : $8.95]
FDA says it is analyzing compounded hydroxyprogesterone caproate products and the bulk APIs used to make them.